Healthcare Professional Interviews: Data Disclosures in Communications About Prescription Drugs

Data to Support Drug Product Communications

Appendix C - Confirmation Email Letter

Healthcare Professional Interviews: Data Disclosures in Communications About Prescription Drugs

OMB: 0910-0695

Document [docx]
Download: docx | pdf

Appendix C

Confirmation Email Letter



Appendix C: Confirmation Email Letter


Dear Dr. [ ];


Thank you for agreeing to participate in a one-hour interview for a study sponsored by the Food and Drug Administration (FDA) about prescription drug information. During the interview you will be asked to log into a secure Internet site to look at some prescription drug informational materials and share your thoughts and opinions about these items with an interviewer. Other research staff from Westat and FDA may also be observing.  The interview will also be audio recorded to facilitate data analysis. In order to protect your privacy, we will only be sharing your first name with the interview team. The attached informed consent document details your rights as a participant in this study.

  • The date and time for your schedule interview is: DATE, TIME

  • The link to the Web site where you will participate in the interview is: WebEx link here

[In the event of difficulties with the link, you can go directly to: www.webex.com; enter the meeting ID (6-digit unique ID for each interview). You will then be prompted to enter a passcode for the meeting, which is (unique passcode for each meeting). If you have any difficult logging in, please contact our HELP DESK at 800/XXX-XXXX.]


As a token of appreciation, you will receive [$200/$275] for completing the interview.


Thank you again for participating in this important study!













File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorAikin, Kathryn J
File Modified0000-00-00
File Created2021-01-15

© 2024 OMB.report | Privacy Policy